The U.S. Food and Drug Administration (FDA) recently announced a recall of Zantac along with all other medications using its active ingredient, Ranitidine. This recall follows new research that found that the Ranitidine used in medications like Zantac was too often contaminated by N-Nitrosodimethylamine (NDMA), a chemical classified as a probable carcinogen by the FDA, the Environmental Protection Agency, and the World Health Organization. According to the U.S. Centers for Disease Control (CDC), NDMA has been linked to a variety of diseases, including severe liver disease, liver cancer, testicular cancer, and lung cancer.
Millions of people used Zantac for years not knowing about the risks they were exposing themselves to, and some users are now suffering from cancer that may have been caused by the drug. Zantac’s manufacturer, Sanofi, had a responsibility to ensure that their customers wouldn’t suffer injury from using their product, and they have failed to meet that responsibility.
Zantac users who have suffered injury deserve compensation, and Hotz & Associates wants to help them get it. If you or a loved one was diagnosed with cancer after using Zantac, give us a call today for a free consultation.